Home

U.S. Virgin Islands

Regulatory Framework

The Virgin Islands Office of Cannabis Regulation (VI-OCR) oversees the entire adult-use and medical cannabis industry in the USVI. It is responsible for licensing and establishing regulations for product safety, labeling, and marketing [1]. The Department of Licensing and Consumer Affairs (DLCA) houses the VI-OCR and provides administrative support for its operations [2]. As of September 2024, adult use sales had not begun in the territory. The Virgin Islands Department of Agriculture has a role in regulating cannabis cultivation, as well as the industrial hemp commission [3].

Legal Status

Market Status
Adult-Use Legal Act No. 8680 (2023) [4]
Medical Legal Bill No. 32-0135 (2019) [5]
Sacramental Legal for registered adults [6]
Homegrow Up to 6 plants legal for patients only

Track-and-Trace

The VI-OCR regulations require an "inventory tracking system" to monitor movement of cannabis products throughout the supply chain, but the specific system has not yet been implemented as of September 2024 [7].

Licensing

The VI-OCR is responsible for issuing licenses for all cannabis related businesses [7]. These include:

  • Cultivation Licenses
  • Manufacturing Licenses
  • Dispensary Licenses
  • Testing Facility License
  • Research and Development License

In addition to a business license, medical practitioners must also be certified by the VI-OCR to recommend cannabis to patients [8].

Possession Limits

Item Possession Limit
Adults (recreational use) 2 ounces of cannabis flower, ½ ounce of concentrated cannabis, 1 ounce of cannabis-infused products (edibles, topicals, etc.) [7]
Medical patients 4 ounces of cannabis flower, 1 ounce of concentrated cannabis, 2 ounces of cannabis-infused products [7]

Medical Cannabis

Patients can register with the VI-OCR to become qualified medical cannabis patients [7]. Qualifying conditions include:

  • Cancer
  • Glaucoma
  • HIV/AIDS
  • Hepatitis C
  • Amyotrophic lateral sclerosis (ALS)
  • Crohn's disease
  • Post-traumatic stress disorder (PTSD)
  • Parkinson's disease
  • Multiple Sclerosis  
  • Severe nausea
  • Autism
  • Any condition for which a practitioner would prescribe an opiate for pain
  • Any other conditions certified by a practitioner where the potential benefits outweigh the risks for the patient

Additional Resources

References